Æȷοì
Jeffrey D. Parvin, MD, PhD
Jeffrey D. Parvin, MD, PhD
Professor of Biomedical Informatics, Ohio State University
osumc.eduÀÇ À̸ÞÀÏ È®ÀÎµÊ - ȨÆäÀÌÁö
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Network modeling links breast cancer susceptibility and centrosome dysfunction
MA Pujana, JDJ Han, LM Starita, KN Stevens, M Tewari, JS Ahn, ...
Nature genetics 39 (11), 1338-1349, 2007
7242007
Amplification, expression, and packaging of a foreign gene by influenza virus
W Luytjes, M Krystal, M Enami, JD Parvin, P Palese
Cell 59 (6), 1107-1113, 1989
7101989
BRCA1 is a component of the RNA polymerase II holoenzyme
R Scully, SF Anderson, DM Chao, W Wei, L Ye, RA Young, DM Livingston, ...
Proceedings of the National Academy of Sciences 94 (11), 5605-5610, 1997
6781997
RNA helicase A mediates association of CBP with RNA polymerase II
T Nakajima, C Uchida, SF Anderson, CG Lee, J Hurwitz, JD Parvin, ...
Cell 90 (6), 1107-1112, 1997
6711997
¥á-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
E Kontopoulos, JD Parvin, MB Feany
Human molecular genetics 15 (20), 3012-3023, 2006
6312006
BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A
SF Anderson, BP Schlegel, T Nakajima, ES Wolpin, JD Parvin
Nature genetics 19 (3), 254-256, 1998
5311998
DNA topology and a minimal set of basal factors for transcription by RNA polymerase II
JD Parvin, PA Sharp
Cell 73 (3), 533-540, 1993
4831993
Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle.
MT Hsu, JD Parvin, S Gupta, M Krystal, P Palese
Proceedings of the National Academy of Sciences 84 (22), 8140-8144, 1987
4161987
BRCA1-dependent ubiquitination of ¥ã-tubulin regulates centrosome number
LM Starita, Y Machida, S Sankaran, JE Elias, K Griffin, BP Schlegel, ...
Molecular and cellular biology 24 (19), 8457-8466, 2004
4062004
Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1
JD Parvin, A Moscona, WT Pan, JM Leider, P Palese
Journal of virology 59 (2), 377-383, 1986
3721986
Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene
DA Buonagurio, S Nakada, JD Parvin, M Krystal, P Palese, WM Fitch
Science 232 (4753), 980-982, 1986
3591986
Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase
P Saha, J Chen, KC Thome, SJ Lawlis, Z Hou, M Hendricks, JD Parvin, ...
Molecular and cellular biology 18 (5), 2758-2767, 1998
3481998
A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II
HM Bourbon, A Aguilera, AZ Ansari, FJ Asturias, AJ Berk, S Bjorklund, ...
Molecular cell 14 (5), 553-557, 2004
3412004
Massively parallel functional analysis of BRCA1 RING domain variants
LM Starita, DL Young, M Islam, JO Kitzman, J Gullingsrud, RJ Hause, ...
Genetics 200 (2), 413-422, 2015
3292015
Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors.
T Nakajima, C Uchida, SF Anderson, JD Parvin, M Montminy
Genes & development 11 (6), 738-747, 1997
3121997
The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair
LM Starita, JD Parvin
Current opinion in cell biology 15 (3), 345-350, 2003
3042003
Patterns and functional implications of rare germline variants across 12 cancer types
C Lu, M Xie, MC Wendl, J Wang, MD McLellan, MDM Leiserson, K Huang, ...
Nature communications 6 (1), 10086, 2015
2972015
Factors associated with the mammalian RNA polymerase II holoenzyme
AS Neish, SF Anderson, BP Schlegel, W Wei, JD Parvin
Nucleic acids research 26 (3), 847-853, 1998
2691998
Recombinant negative strand rna virus expression-systems
P Palese, JD Parvin, M Krystal
US Patent 5,166,057, 1992
2581992
Pre-bending of a promoter sequence enhances affinity for the TATA-binding factor
JD Parvin, RJ McCormick, PA Sharp, DE Fisher
Nature 373 (6516), 724-727, 1995
2421995
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20